M
MBX Biosciences Inc
NASDAQ:MBX
MBX Biosciences Inc
NASDAQ:MBX
Price:
37.68
USD
1.76%
Market Closed
Market Cap:
$1.7B
Income Statement
Earnings Waterfall
MBX Biosciences Inc
MBX Biosciences Inc
Income Statement
MBX Biosciences Inc
MBX Biosciences Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||
| Operating Expenses |
(57)
|
(65)
|
(85)
|
(68)
|
(81)
|
(87)
|
(91)
|
|
| Selling, General & Administrative |
(11)
|
(11)
|
(14)
|
(11)
|
(13)
|
(14)
|
(16)
|
|
| Research & Development |
(46)
|
(54)
|
(71)
|
(57)
|
(69)
|
(72)
|
(75)
|
|
| Operating Income |
(57)
N/A
|
(65)
-15%
|
(85)
-30%
|
(68)
+20%
|
(81)
-19%
|
(87)
-6%
|
(91)
-5%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
4
|
5
|
6
|
6
|
8
|
10
|
10
|
|
| Pre-Tax Income |
(53)
N/A
|
(61)
-16%
|
(79)
-30%
|
(62)
+22%
|
(73)
-19%
|
(77)
-5%
|
(80)
-5%
|
|
| Net Income | ||||||||
| Income from Continuing Operations |
(53)
|
(61)
|
(79)
|
(62)
|
(73)
|
(77)
|
(80)
|
|
| Net Income (Common) |
(53)
N/A
|
(61)
-16%
|
(79)
-30%
|
(62)
+22%
|
(73)
-19%
|
(77)
-5%
|
(80)
-5%
|
|
| EPS (Diluted) |
-1.65
N/A
|
-1.91
-16%
|
-2.36
-24%
|
-5.82
-147%
|
-2.19
+62%
|
-2.3
-5%
|
-2.35
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
